UCART019
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCART019, covering 2017-06-23 to 2017-06-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma [Phase 1, Phase 2]